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ABSTRACT
Oxidative stress caused by free radicals has been 
implicated in several human disorders. Dietary antioxi-
dants can help the body to counteract those reactive 
species and reduce oxidative stress. Antioxidant activ-
ity is one of the multiple health-promoting attributes 
assigned to bovine whey products. The present study 
investigated whether this activity was retained during 
upper gut transit using a static simulated in vitro gas-
trointestinal digestion (SGID) model. The capacity to 
scavenge free radicals and reduce ferric ion of whey 
protein isolate (WPI), individual whey proteins, and 
hydrolysates pre- and post-SGID were measured and 
compared using various antioxidant assays. In addition, 
the free AA released from individual protein fractions 
in physiological gut conditions were characterized. Our 
results indicated that the antioxidant activity of WPI 
after exposure to the harsh conditions of the upper gut 
significantly increased compared with intact WPI. From 
an antioxidant bioactivity viewpoint, this exposure ne-
gates the need for prior hydrolysis of WPI. The whey 
protein α-lactalbumin showed the highest antioxidant 
properties post-SGID (oxygen radical absorbance ca-
pacity = 1,825.94 ± 50.21 μmol of Trolox equivalents/g 
of powder) of the 4 major whey proteins tested with 
the release of the highest amount of the antioxidant 
AA tryptophan, 6.955 μmol of tryptophan/g of pro-
tein. Therefore, α-lactalbumin should be the preferred 
whey protein in food formulations to boost antioxidant 
defenses.
Key words: whey protein hydrolysis, antioxidant 
activity, simulated gastrointestinal digestion, 
α-lactalbumin
INTRODUCTION
Antioxidants are widely used in the food industry 
to prevent food oxidation and provide health benefits 
to the consumer by combating oxidative stress (Capi-
tani et al., 2009). Oxidative stress occurs due to an 
imbalance between the elimination and production of 
reactive oxygen, nitrogen, and sulfur species (Li et al., 
2015). Dietary antioxidants, both soluble and insoluble, 
can reduce oxidative stress through different pathways, 
including scavenging free radicals by electron or hy-
drogen atom transfer (Lü et al., 2010). Antioxidants 
from plants (polyphenols, carotenoids, and vitamins) 
are widely accepted as natural antioxidants (Fiedor 
and Burda, 2014). Once ingested, these bioactive com-
pounds or their metabolites survive gut transit and are 
transported across the intestinal barrier to reach their 
target organs (Sarmadi and Ismail, 2010; Quirós-Sauce-
da et al., 2017). Recently, animal-derived proteins from 
eggs, meat, and milk have been described as a source 
of antioxidants (Cloetens et al., 2013; Nimalaratne and 
Wu, 2015; Liu et al., 2016). In particular, products de-
rived from bovine whey, such as whey protein isolate 
(WPI) and whey protein concentrate (WPC), have 
been extensively tested for antioxidant potential in vi-
tro (O’Keeffe and FitzGerald, 2014; Önay-Ucar et al., 
2014; Torkova et al., 2016). Indeed, recent human in-
tervention studies with whey product supplementation 
have reported increased levels of different antioxidant 
biomarkers in plasma, such as glutathione (de Aguilar-
Nascimento et al., 2011; Power-Grant et al., 2016). 
Dried whey protein-based ingredients differ primar-
ily in the percentage of protein, fat, and lactose, with 
WPI containing the highest protein concentration at 90 
to 95%. The protein component is considered to har-
bor the antioxidant activity and is composed of β-LG 
(50–60%), α-LA (15–25%), BSA (6%), lactoferrin (LF; 
<3%), and immunoglobulins (<1%; Madureira et al., 
2007). In an effort to increase the antioxidant potency 
of commercial whey, different processing methods [en-
zymatic hydrolysis (Zhidong et al., 2013), fractionation 
(Hernández-Ledesma et al., 2005), thermal treatment 
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(Adjonu et al., 2013), pressure treatment (Iskandar et 
al., 2015), acid treatment (Mohammadian and Madad-
lou, 2016), and polymerization (Ortega et al., 2015)] 
have been assessed. It is generally agreed that enzymat-
ic hydrolysis and fractionation increase the antioxidant 
properties of whey (Power et al., 2013). Hydrolysis with 
the enzyme alcalase (EC 3.4.21.62) commonly delivers 
the most potent antioxidant fractions (Lin et al., 2012; 
Zhang et al., 2013). In addition, whey fractions with a 
molecular weight below 5 kDa consistently exert better 
antioxidant properties than higher-molecular weight 
fractions (de Castro and Sato, 2014; Liu et al., 2014; 
O’Keeffe and FitzGerald, 2014). Recently, Bamdad et 
al. (2017) identified 8 peptides present in the most an-
tioxidant fraction of β-LG hydrolyzed by alcalase.
Once ingested in vivo, whey products are subjected 
to the chemical (acidic), physical (peristaltic), and 
enzymatic degradation process of the gastrointestinal 
tract (Guerra et al., 2012). Given the hydrolytic condi-
tions prevailing in the gastrointestinal tract, it could be 
argued that enzymatic hydrolysis during whey process-
ing is an unnecessary step to provide the body with 
antioxidant whey. Indeed, digestion of foods that con-
tain hydrolyzed whey proteins may result in the pre-
mature loss of antioxidant activity during gut transit, 
as hydrolyzed proteins are more easily broken down to 
individual AA compared with intact protein complexes 
(Koopman et al., 2009).
Therefore, the objectives of our study were to investi-
gate, under simulated in vitro gastrointestinal digestion 
(SGID) conditions, whether commercial WPI exposed 
to the harsh conditions of the upper gut had similar 
antioxidant activity to WPI hydrolysates prepared with 
commercial enzymes. We hypothesized that transit of 
WPI through the upper gut would increase its antioxi-
dant bioactivity to levels comparable to WPI hydroly-
sate preparations. In addition, individual whey protein 
fractions (intact and postsimulated upper gut transit) 
were assayed for antioxidant activity to ascertain the 
most potent antioxidant product by testing their capac-
ity to counteract free radicals and reduce ferric ion.
MATERIALS AND METHODS
Materials
Commercial bovine WPI (Isolac, 91.4% protein con-
tent) was purchased from Carbery Food Ingredients 
(Ballineen, Co. Cork, Ireland). Individual whey pro-
teins were sourced from food industries as representa-
tive of commercial products, except BSA (98% protein 
content) which was purchased from Sigma-Aldrich 
(Dublin, Ireland). The proteins β-LG (92.1% β-LG 
content) and α-LA (93% α-LA content) were obtained 
from Davisco Foods International, Inc. (Le Sueur, MN). 
The LF (Bioferrin 2000, 95% LF content) was donated 
by Glanbia Nutritionals, Inc. (Fitchburg, WI). Brome-
lain (EC 3.4.22.32) was from Kerry Foods Ingredients 
(Kilnagleary, Carrigaline, Co. Cork, Ireland), whereas 
alcalase 2.4 U and neutrase 0.8 L (EC 3.4.24.28) were 
from Novozymes (Bagsvaerd, Denmark). Reagents were 
purchased from Sigma-Aldrich unless stated otherwise.
Enzymatic Hydrolysis of WPI
Protein powder (WPI 10%, wt/vol) was hydrated in 
Milli-Q H2O (300 mL) at 4°C stirring overnight. The 
protein solution was warmed at 50°C for 15 min before 
starting the hydrolysis. Hydrolysates were produced 
using the commercial enzymes alcalase (2.4 Anson 
units/g), bromelain (600 gelatin digestion units/g), or 
neutrase (0.8 Anson units/g) at an enzyme-to-substrate 
ratio of 1:100 (g/g) for 180 min in a water bath at 
50°C with continuous stirring. The pH was maintained 
constant at 8.0 for alcalase or 7.0 for bromelain and 
neutrase with 2 M solution of NaOH using a Metrohm 
842 Titrando dosing unit (Metrohm Ltd., Herisau, 
Switzerland). After 180 min, the hydrolysis was stopped 
by inactivating the enzymes in a water bath at 90°C for 
10 min. Hydrolysates were freeze-dried and stored at 
−80°C for further use. Degree of hydrolysis (DH) of 
these products was determined according to the follow-
ing equation (Adler-Nissen, 1986):
 %DH
B  N
M  h  
B
TOT
=
⋅
⋅ ⋅
⋅
α
100, 
where B (mL) is the amount of alkaline solution em-
ployed, NB (mol/L) is the molarity of the NaOH aque-
ous solution used, M (g) is the protein mass reacting, 
hTOT (mEq/g) is the number of total peptides bonds 
contained in the protein, and α is the dissociation de-
gree of α-amino groups that are released during protein 
hydrolysis. The values hTOT (8.8 mEq/g) and α, at pH 7 
(0.441) and 8 (0.885), were obtained from Adler-Nissen 
(1986).
Simulated Gastrointestinal Digestion Static Model
An in vitro SGID was performed according to an 
established INFOGEST method (Figure 1; Minekus et 
al., 2014). Oral phase was not performed, as 1 g of 
protein powder was reconstituted in 5 mL of Milli-Q 
H2O. Gastric phase was started by mixing 1 g of recon-
stituted protein powder with 2 mL of simulated gastric 
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fluid. We then added 2.5 mL of a fresh stock solution 
(8,000 U/mL) of porcine pepsin (EC 3.4.23.1) to reach 
2,000 U/mL activity; pH was adjusted to 3.0 manually 
using HCl (1 M) and volume brought up to 10 mL with 
Milli-Q H2O. The mixture was incubated for 2 h at 
37°C with continuous shaking. Pepsin was inactivated 
by increasing pH to 6.5 manually using NaOH (1 M) 
and by diluting 5 parts of gastric chyme with 4 parts 
of simulated intestinal fluid. After addition of pancre-
atin, bile extract, and water, the final ratio of gastric 
chyme to simulated intestinal fluid was 50:50 (vol/vol). 
Pancreatin (EC 232.468.9) and bile extract prepared in 
simulated intestinal fluid were added to achieve a final 
concentration of 200 U/mL and 10 mM, respectively. 
The pH was adjusted to 7.0, the volume brought up to 
20 mL, and the mixture was again incubated for 2 h 
at 37°C with continuous shaking. After this time, the 
digestion was stopped by adding the protease inhibi-
tor 4-(2-aminoethyl) benzenesulfonyl fluoride hydro-
chloride at a final concentration of 1 mM. The final 
sample concentration after SGID was 50 mg of protein 
powder/mL. Samples were aliquoted, snap-frozen in 
liquid nitrogen, and stored at −80°C before analysis. 
On experimental days, samples were defrosted on ice 
and diluted, according to the final powder concentra-
tion after SGID, to the corresponding assay concentra-
tion. The SGID control contained pepsin, pancreatin, 
and bile salts and it was incubated for the same time as 
whey test samples. Protease inhibitor was then added 
and snap frozen.
Determination of the DH 
The extent of hydrolysis was determined using the 
2,4,6-trinitrobenzene 1-sulfonic acid (TNBS) method 
developed by Fernández and Kelly (2016) based on 
Adler-Nissen (1979). Samples were prepared at 50 mg/
mL and diluted 1:10 in Milli-Q H2O prior to assay. Di-
luted samples (10 μL) were mixed with 140 μL of SDS 
(1%) and 1 mL of sodium phosphate buffer (0.2125 M, 
Figure 1. Antioxidant results for nongastrointestinal-digested (black bars) and simulated gastrointestinal-digested (gray bars) whey protein 
isolate (WPI) and WPI hydrolysates prepared by alcalase (ALC)-, bromelain (BRO)-, or neutrase (NEU)-based hydrolysis. (A) 2,2′-Azinobis(3-
ethylbenzothiazoline-6-sulfonic acid) (ABTS) values expressed as percent radical inhibition, with samples tested at 15 mg/mL. Results represent 
the mean of 2 experimental repetitions ± SD (n = 4). (B) Ferric-reducing antioxidant power (FRAP) values expressed as micromoles of Trolox 
equivalents (TE) per gram of powder, samples tested at 15 mg/mL. Results represent the mean of 2 experimental repetitions ± SD (n = 4). 
(C) Oxygen radical absorbance capacity (ORAC) values expressed as micromoles of TE per gram of powder. Results represent the mean of 2 
experimental repetitions ± SD (n = 6). Samples with different letters (a–e) are significantly different (P < 0.05).
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pH 8.2). We then added 1 mL of 1 mg/mL TNBS solu-
tion to each tube. Tubes were mixed and incubated 1 h 
in a covered water bath (50°C). Reaction was stopped 
by adding 2 mL of HCl (0.1 M). Samples were allowed 
to cool at room temperature for 30 min and absorbance 
was measured at 340 nm on a Cary 100 Spectropho-
tometer (Agilent Technologies, Santa Clara, CA). A 
standard curve using l-leucine was performed to estab-
lish the relationship between amino nitrogen content 
and absorbance. Degree of hydrolysis was determined 
by comparing the quantity of free amino groups pre- 
and postprotein digestion. The following equation was 
used to calculate the DH of SGID samples:
 %DH = (AN2 − AN1/Npb) × 100, 
where AN1 and AN2 are the amino nitrogen content 
(mg/g of protein) of the protein substrate before and 
after digestion, respectively, and Npb is the nitrogen 
content of the peptide bonds in the protein substrate 
(mg/g protein). This value is 123.3 mg/g of protein for 
whey protein (Adler-Nissen, 1979).
Free AA Determination
Free AA were determined according to McDermott 
et al. (2016). Samples after SGID were deproteinized 
by mixing equal volume of test sample with 24% (wt/
vol) trichloroacetic acid. The solution was allowed to 
stand for 10 min before centrifuging at 14,400 × g 
(Microcentaur, MSE, London, UK) for 10 min at 4°C. 
Supernatants were removed and diluted with 0.2 M so-
dium citrate buffer, pH 2.2. Samples were then diluted 
1 in 2 with the internal standard, norleucine, to give a 
final concentration of 125 nmol/mL. Amino acids were 
quantified using a Jeol JLC-500/V amino acid analyzer 
(Jeol Ltd., Garden City, Herts, UK) fitted with a Jeol 
Na+ high-performance cation exchange column.
Reverse-Phase HPLC and SDS-PAGE
Hydrolysates, intact whey proteins, the correspon-
dent SGID samples, and the SGID control were ana-
lyzed by reverse-phase HPLC in an Agilent 1200 Series 
with a binary pump and a diode array detector using 
ChemStation for LC 3D Systems software (Agilent 
Technologies). Protein and peptide separation was per-
formed at 35°C using an Agilent ZORBAX StableBond 
300SB-C18 column (4.6 × 150 mm, 5 μm) with a pre-
column security guard (Agilent Technologies). Samples 
were prepared at a concentration of 0.2% (wt/vol) in 
Milli-Q water and 8 μL was injected onto the column 
after filtration through a 0.45-μm polyethersulfone sy-
ringe filter (Sarstedt AG & Co., Nümbrecht, Germany). 
Mobile phase A was 0.1% trifluoroacetic acid in Milli-
Q water and phase B was 0.1% trifluoroacetic acid in 
HPLC-grade acetonitrile. The flow rate was 0.8 mL/
min and the linear gradient elution was 0 to 10 min 
of 5% B; 10 to 20 min of 10% B; 20 to 22 min of 15% 
B; 22 to 25 min of 20% B; 25 to 30 min of 30% B; 30 
to 50 min of 90% B; and 50 to 54 min of 0% B. The 
absorbance of the eluent was recorded at 214 nm.
We employed SDS-PAGE to analyze protein profile 
pre- and post-SGID (Laemmli, 1970). Samples were 
prepared under nonreducing conditions and run on Nu-
PAGE Novex 4–12% gradient Bis-Tris Mini Gel (Invi-
trogen, Carlsbad, CA). The Running Buffer MES SDS 
(Invitrogen) was used with a Xcell SureLock Novex 
Mini Cell apparatus (Invitrogen). Mark12 Unstained 
Standard (Invitrogen) was used as the molecular weight 
standard. Detection of protein bands was performed 
by gel staining with 0.05% Coomassie blue solution 
(Fisher Scientific, Hampton, NH).
Measurement of 2,2′-Azinobis(3-
Ethylbenzothiazoline-6-Sulfonic Acid)  
Radical Scavenging Activity
The measurement of the 2,2′-azinobis(3-ethylbenzo-
thiazoline-6-sulfonic acid) (ABTS) radical scavenging 
activity was performed as described by Re et al. (1999) 
with some modifications. Potassium phosphate mono-
basic and dibasic were mixed to prepared a potassium 
phosphate buffer (PB) at pH 7.0. A 5 mM potassium 
persulfate solution was prepared in Milli-Q H2O. The 
ABTS diammonium salt radical (7.3 mM) was formed 
by adding 2 tablets of 10 mg in 5 mM potassium per-
sulfate solution, stirring overnight at 4°C in darkness. 
Absorbance of diluted ABTS solution (1:10 in PB) at 
734 nm was around 0.4. After incubation overnight, 
the formation of the radical was checked by spectro-
photometry (absorbance: 0.8–1.1). The ABTS radical 
solution was then diluted 1:100 in 10 mM PB (pH 7.0) 
and, immediately before use, the absorbance at 734 nm 
was checked (0.8–1.1). This solution was kept on ice 
in the dark to preserve stability. Protein samples were 
prepared in Milli-Q H2O at 15 mg of powder/mL. The 
incubation was performed in the spectrophotometer 
sample holder to ensure dark conditions and eliminate 
time lost due to sample transfer after the start of the 
reaction. To perform the assay, 5 μL of sample or PB 
(control vehicle) was added to a cuvette placed in the 
spectrophotometer, which contained 1 mL of ABTS free 
radical solution. The mixture was homogenized with a 
pipette and the absorbance was read after 5 min on a 
Cary 100 Spectrophotometer (Agilent Technologies) at 
734 nm. Antioxidant activity was expressed as percent 
ABTS radical inhibition using the formula:
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 % radical inhibition = [(Abs734 control vehicle   
− Abs734 sample)/Abs734 control vehicle] × 100,
where Abs734 control vehicle is the absorbance measured 
at 734 nm of PB with ABTS radical solution after 5 
min of incubation. Abs734 sample is the absorbance of 
samples reacting with the radical solution after 5 min. 
A control for the gastrointestinal fluids, including ions, 
enzymes, and bile extract, was run and the antioxidant 
value obtained was subtracted from each SGID sample 
result.
Ferric-Reducing Antioxidant Power Assay
Ferric-reducing antioxidant power (FRAP) protocol 
was performed according to Benzie and Strain (1996) 
with some modifications to achieve optimum conditions 
for dairy protein tests. The traditional acetate buffer 
has a pH of 3.6, close to the whey acid dissociation con-
stant value (4.6), resulting in protein precipitation. As 
an alternative, 0.2 M HCl/KCl buffer (pH = 2.2) was 
used. A 10 mM 2,4,6-tris(2-pyridyl)-s-triazine (TPTZ) 
solution was prepared in 40 mM HCl. A 20 mM FeCl3 
solution was prepared using Milli-Q H2O. All stock 
solutions were prepared fresh on the experiment day 
and kept in darkness to avoid photo-oxidation. A work-
ing FRAP solution was prepared at low pH by mixing 
0.2 M HCl-KCl (pH 2.2) with 10 mM TPTZ-HCl and 
20 mM FeCl3 at a ratio of 10:1:1. This solution was 
protected from light and heated to 37°C for at least 1 
h in a water bath. Test samples were prepared in Milli-
Q H2O at 15 mg of powder/mL. Trolox (a synthetic 
analog of vitamin E) was initially dissolved in 200 μL of 
pure methanol. Then a stock solution was prepared and 
serial dilutions (800–25 μM) in Milli-Q H2O were used 
to generate a standard curve. The reaction was initi-
ated by adding 75 μL of sample to 1.425 mL of FRAP 
working solution in black microcentrifuge tubes. The 
mixture was vortexed and allowed to incubate for 1 h at 
room temperature in complete darkness. After incuba-
tion, tubes were vortexed and the absorbance was read 
at 593 nm on a Cary 100 Spectrophotometer (Agilent 
Technologies). Results were expressed as micromoles 
of Trolox equivalents (TE) per gram of powder. The 
antioxidant value for the gastrointestinal fluids was 
subtracted from SGID sample results.
Oxygen Radical Absorbance Capacity Assay
The oxygen radical absorbance capacity (ORAC) 
assay protocol was adapted from Zulueta et al. (2009). 
A potassium PB at 75 mM, pH 7.2, was prepared. 
Digested assays were run using 0.05 mg/mL of test 
samples and then expressed per gram of powder. In-
tact assays were run using 0.1 mg/mL of test samples 
and expressed as above. Samples, standards, or vehicle 
control (PB; 20 μL) were pipetted into a black 96-well 
microtiter plate followed by 120 μL of 0.117 μM fluo-
rescein solution, freshly prepared in PB. The plate was 
incubated at 37°C for 15 min. During this period, a 
40 mM 2,2′-azobis(2-methylpropionamidine) dihydro-
chloride (APPH) radical solution was prepared in 
preheated PB and kept at 37°C. After incubation, 60 
μL of APPH solution were added to each well. The 
fluorescence was immediately read at 90-s intervals 
for 2 h in a Synergy HT BioTek micro plate reader 
(Winooski, VT). A standard curve was performed with 
Trolox at 5 different concentrations ranging from 80 to 
5 μM prepared in 75 mM PB. Trolox was initially dis-
solved in 200 μL of methanol, as described previously. 
Fluorescence data were normalized and area under the 
curve was calculated. The antioxidant reaction was 
considered to be finished if the final fluorescence was 
less than 5% of the initial value. Antioxidant activity 
was expressed as micromoles of TE per gram of powder. 
The antioxidant value for the gastrointestinal fluids 
was subtracted from SGID sample results.
Statistical Analysis
Results were compared using one-way ANOVA fol-
lowed by Bonferroni’s multiple comparison post-hoc 
test using PASW Statistics 18 software; a P-value less 
than 0.05 was considered to indicate a statistically sig-
nificant difference. Results were expressed as mean ± 
standard deviation. Each experiment was repeated at 
least in duplicate and on different days.
RESULTS
In Vitro Antioxidant Activity of WPI
The antioxidant activity of intact WPI and WPI 
hydrolysates prepared by 3 individual commercial en-
zymes (bromelain, neutrase, and alcalase) is detailed in 
Figure 1. Bromelain, a cysteine protease obtained from 
pineapple (Abadía-García et al., 2016), was selected 
because it exposes the reactive thiol group of cysteine 
residues so that they are available to reduce oxidative 
agents such as peroxyl radicals. Neutrase is a bacte-
rial metalloprotease, commonly used to improve food 
protein functionality with an affinity for the AA leucine 
and phenylalanine (Xu et al., 2014). Alcalase is a non-
specific endopeptidase purified from Bacillus lichenifor-
mis. Not surprisingly, commercial enzyme hydrolysates 
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showed significantly higher ABTS and FRAP values 
than intact WPI (P < 0.05). In particular, alcalase hy-
drolysis of WPI resulted in 76.41 ± 2.67% ABTS radi-
cal inhibition, 26.96 ± 1.18 μmol of TE/g of powder by 
FRAP, and 737.36 ± 67.24 μmol of TE/g of powder by 
ORAC assay compared with intact WPI (6.98 ± 0.18% 
ABTS radical inhibition, 3.81 ± 0.46 μmol of TE/g of 
powder by FRAP, and 128.74 ± 48.36 μmol of TE/g 
of powder by ORAC; Figure 1A, B and C). Bromelain 
and neutrase hydrolysis of WPI resulted in significantly 
higher antioxidant activity than intact WPI by FRAP 
and ABTS (P < 0.05), but we observed no difference 
in TE as determined by ORAC (Figure 1A, B and C).
The standardized INFOGEST static in vitro diges-
tion model was employed to ascertain if simulated 
upper gut transit altered the antioxidant bioactivity 
of these WPI samples (Figure 1). In all 3 assays, the 
antioxidant activity of WPI was significantly increased 
post-SGID (P < 0.05). Remarkably, when subjected to 
the hydrolytic conditions of the gastrointestinal tract, 
whey hydrolysates produced by alcalase exhibited 
significantly lower FRAP and ABTS inhibition than 
the alcalase-hydrolyzed sample without gastric diges-
tion (Figure 1A and B). However, ORAC activity was 
increased by SGID of the WPI hydrolysate prepared by 
alcalase (1,144.73 ± 83.86 μmol of TE/g of powder). 
Reduction in antioxidant activity by FRAP and ABTS 
inhibition, but not by ORAC, was also observed with 
the bromelain-hydrolyzed WPI (Figure 1A, B, and C). 
The WPI hydrolyzed by neutrase and subjected to SGID 
exhibited significantly (P < 0.05) lower antioxidant 
activity by ABTS inhibition but significantly higher 
antioxidant activity by ORAC and FRAP (Figure 1A, 
B, and C). Interestingly, subjecting commercial WPI 
to hydrolysis by either bromelain or neutrase before 
SGID did not enhance its antioxidant activity, 799.93 
± 56.68 and 908.65 ± 126.11 μmol of TE/g of powder, 
respectively, compared with WPI post-SGID (885.18 
± 121.91 μmol of TE/g of powder) as determined by 
ORAC. Only alcalase hydrolysis contributed to higher 
ORAC value post-SGID compared with the results ob-
tained for WPI post-SGID. Hydrolysates generated by 
alcalase or bromelain had similar FRAP capabilities to 
WPI post-SGID (Figure 1B). Only neutrase hydrolysis 
of WPI post-SGID was significantly better at reducing 
ferric ions than WPI post-SGID. In the case of ABTS 
inhibition, commercial enzyme hydrolysis of WPI was 
not significantly different post-SGID compared with 
WPI post-SGID (Figure 1A). Antioxidant activity 
measured after SGID of WPI was significantly higher 
when measured by ORAC compared with the hydroly-
sates prepared with the commercial enzymes bromelain 
or neutrase (Figure 1C). The FRAP capability of WPI 
post-SGID was similar to alcalase- and bromelain-hy-
drolyzed WPI (Figure 1B). The WPI post-SGID inhib-
ited less ABTS (26.02 ± 1.84%) than alcalase (76.41 ± 
2.67%), bromelain (38.33 ± 1.91%), or neutrase (41.69 
± 6.89%) hydrolyzed WPI (Figure 1A).
DH of WPI
To compare the extent of hydrolysis, DH values 
were obtained for whey samples. The WPI post-SGID 
had a DH of 49.96%, with alcalase hydrolysis of WPI 
yielding 13.60% followed by neutrase, 5.28%, and bro-
melain, 4.31%. However, the comparative kinetics have 
not been investigated here. Degradation of WPI after 
hydrolysis with commercial enzymes and after SGID 
was also evaluated by HPLC (Figure 2). The profile of 
intact WPI revealed clear peaks correspondent to the 
caseinomacropeptide, BSA, α-LA, and β-LG (retention 
times of 31–42 min). The use of alcalase, bromelain, 
and neutrase showed distinct WPI peptide peaks ex-
plained by the diverse enzyme specificity. Fractions at 
lower retention times contained hydrophilic peptides 
with higher polarity, whereas hydrophobic peptides 
with less polarity were eluted at higher retention 
times. Alcalase hydrolysis resulted in a large number of 
peaks, primarily at 24 to 33 min. However, bromelain 
hydrolysates, with the lowest DH, had the least number 
of peptide peaks (18–19 and 29–31 min). The major 
peptides obtained after neutrase hydrolysis appeared 
at the highest retention time (24–39 min), which could 
explain its poor solubility in water. The chromatograms 
of each hydrolysate showed further degradation of whey 
peptides after being exposed to gut conditions. After 
this breakdown, hydrolysates presented similar HPLC 
profiles to the chromatogram obtained for WPI after 
SGID. The HPLC profiles of SGID samples revealed 
several peaks that corresponded to the hydrolytic activ-
ity of pancreatin. The HPLC profile of SGID control 
did not indicate significant autocatalysis.
In Vitro Antioxidant Activity  
of Individual Whey Proteins
To identify which whey protein fraction contributed 
to greater antioxidant activity, individual whey pro-
teins β-LG, α-LA, BSA, and LF were assessed for their 
antioxidant activity before and after SGID (Figure 3). 
Intact α-LA (20.97 ± 1.44%) and LF (18.06 ± 0.44%) 
were the most effective at inhibiting the radical cation 
ABTS compared with the other intact proteins (P > 
0.05). These samples also exerted the most potent ferric 
to ferrous ion reduction, tested by FRAP assay (intact 
α-LA = 8.19 ± 1.19 μmol of TE/g of powder; intact 
LF = 7.85 ± 0.84 μmol of TE/g of powder). All intact 
proteins showed peroxyl radical inhibition with values 
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ranging from 117.65 ± 37.23 μmol of TE/g of powder 
for LF and 365.14 ± 46.07 μmol of TE/g of powder 
for α-LA. Antioxidant activity of all proteins appeared 
significantly enhanced after 240 min of exposure to the 
pH and enzymes of the stomach and duodenum. Of 
note was α-LA post-SGID, which exhibited the highest 
antioxidant activity by all 3 methods (37.29 ± 0.73% 
ABTS inhibition; FRAP = 15.56 ± 1.21 μmol of TE/g 
of powder; ORAC = 1,825.94 ± 50.21 μmol of TE/g of 
powder).
DH of Individual Whey Proteins by Simulated  
Upper Gut Transit
The DH of whey protein samples was determined 
after SGID by the TNBS method. Values ranged from 
Figure 2. Reverse-phase HPLC profiles at 214 nm for whey protein isolate (WPI) and whey protein hydrolysates. Samples were prepared 
at 2 mg/mL and eluted in 0.1% trifluoroacetic acid. (A) Intact WPI and the graph below it simulated gastrointestinal-digested (SGID) WPI, 
where individual peaks correspond to (1) caseinomacropeptide, (2) BSA, (3) α-LA, and (4) β-LG; (B) WPI hydrolyzed with alcalase for 180 min 
at 50°C, pH 8.0, with an enzyme-to-substrate ratio of 1:100 and associated SGID sample; (C) WPI hydrolyzed with bromelain for 180 min at 
50°C, pH 7.0, with an enzyme-to-substrate ratio of 1:100 and associated SGID sample; and (D) WPI hydrolyzed with neutrase for 180 min at 
50°C, pH 7.0, with an enzyme-to-substrate ratio of 1:100 and associated SGID sample. Pancreatin peaks from SGID process are indicated by P. 
The HPLC profiles of SGID control without WPI were also performed. AU = arbitrary units.
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49.96 ± 1.95% for WPI to 65.10 ± 4.61% for BSA 
(Table 1). The chromatograms of the intact whey pro-
teins (Figure 4) showed distinct peaks (β-LG = 40–42 
min, α-LA = 38.5–40 min, BSA = 37.5–39.5 min, LF = 
33 and 38.5–39.5 min), indicating a high level of native 
conformation. After SGID, these peaks disappeared, 
which indicated native protein degradation. The loss 
of each intact whey protein after the harsh conditions 
of the stomach and duodenum was supported by SDS-
PAGE (Figure 5).
Free AA Content in Gastrointestinal-Digested  
Whey Proteins
To determine if the high antioxidant activity of α-LA 
could be explained by the free AA released after SGID, 
AA analysis was performed on WPI and individual 
whey protein fractions post-SGID (Table 2). The high-
est concentration of free AA (50.426 μmol of AA/g 
of powder) was released from α-LA. Leucine was the 
predominant AA in SGID of WPI, β-LG, BSA, and LF 
(6.208–8.154 μmol/g of powder). Lysine was the most 
abundant (8.154 μmol/g of powder) AA found in α-LA 
post-SGID. Interestingly, proline was not detected in 
any of the samples, which can be explained by the lack 
of specificity of the human gastrointestinal enzymes 
for this AA. Known antioxidant AA, such as trypto-
phan, phenylalanine, tyrosine, cysteine, and histidine 
(Hernández-Ledesma et al., 2005; Power-Grant et al., 
2016), were present at relatively high concentrations in 
all SGID samples compared with other AA. Interest-
ingly, α-LA released the highest amount of tryptophan 
(6.955 μmol/g of powder).
DISCUSSION
Our in vitro studies indicate that the hydrolytic con-
ditions of the gut negate the need for prior hydrolysis 
of WPI from an antioxidant bioactivity viewpoint. The 
α-LA, of the 4 major whey protein fractions studied, 
showed the highest antioxidant properties post-SGID 
Figure 3. Antioxidant results for intact (black bars) and simulated 
gastrointestinal-digested (gray bars) proteins. (A) 2,2′-Azinobis(3-
ethylbenzothiazoline-6-sulfonic acid) (ABTS) values are expressed as 
percent ABTS radical inhibition, samples tested at 15 mg/mL. Results 
represent the mean of 2 experimental repetitions ± SD (n = 4). (B) 
Ferric-reducing antioxidant power (FRAP) values are expressed as 
micromoles of Trolox equivalents (TE) per gram of powder, samples 
tested at 15 mg/mL. Results represent the mean of 2 experimental 
repetitions ± SD (n = 4). (C) Oxygen radical absorbance capacity 
(ORAC) values are expressed as micromoles of TE per gram of pow-
der. Results represent the mean of 2 experimental repetitions ± SD 
(n = 6). WPI = whey protein isolate; LF = lactoferrin. Samples with 
different letters (a–f) are significantly different (P < 0.05).
Table 1. Degree of hydrolysis (DH, %) of whey protein isolate 
(WPI) and individual whey protein fractions following simulated 
gastrointestinal digestion (SGID)
Sample1 DH (%)
SGID WPI 49.96 ± 1.95a
SGID β-LG 64.78 ± 4.66ab
SGID α-LA 57.59 ± 1.06ab
SGID BSA 65.10 ± 4.61b
SGID LF 62.62 ± 0.91ab
a,bSamples with different letters are significantly different (P < 0.05).
1Samples tested at 5 mg/mL, LF = lactoferrin.
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when tested by ORAC, ABTS, and FRAP. This ap-
pears to accord with a high level of digestion (57.59% 
DH) and greatest release of the antioxidant AA trypto-
phan, 6.955 μmol of tryptophan/g of protein.
Conditions in the stomach and duodenum (pepsin, 
trypsin, chymotrypsin, and acidic pH) appear to func-
tionalize WPI in reducing ferric ions, inhibiting ABTS 
and scavenging peroxyl radicals possibly by the release 
of bioactive peptides and AA. In agreement, Power-
Grant et al. (2015) observed that WPC exposed to 
simulated SGID had significantly higher ORAC values 
(36,305 ± 3,390 μmol of Trolox/100 g of powder) than 
Figure 4. Reverse-phase HPLC profiles at 214 nm for individual whey proteins at 2 mg/mL and eluted in 0.1% trifluoroacetic acid. (A) Intact 
β-LG and the graph below it simulated gastrointestinal-digested (SGID) β-LG; (B) intact α-LA and SGID α-LA; (C) intact BSA and SGID 
BSA; and (D) intact lactoferrin and SGID lactoferrin. P = peaks corresponding to pancreatin; AU = arbitrary units.
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intact WPC (13,662 ± 1,018 μmol of Trolox/100 g 
of powder). Similar to our study, antioxidant activity 
post-SGID was similar to that obtained with WPC hy-
drolyzed (32% DH) beforehand (37,391 ± 2,298 μmol of 
Trolox/100 g of powder). Interestingly, prior hydrolysis 
of WPC appeared to influence the antioxidant activity 
after simulated upper gut transit. The WPC with a 
DH of 45% at processing and then subjected to gastric 
conditions exhibited 60,613 ± 4,540 μmol of TE/100 
g by ORAC assay, whereas a WPC hydrolysate (32% 
DH) when subjected to gastric conditions had 44,489 ± 
2,064 μmol of TE/100 g. Of note was the significant de-
crease in ORAC values for the WPC hydrolysate (DH 
45%) post-SGID compared with its non-SGID equiva-
lent. We found no differences in ORAC values between 
the WPC hydrolysate DH 32% pre- and post-SGID. In 
contrast, other forms of processing designed to denature 
whey proteins, such as high hydrostatic pressure, may 
increase antioxidant activity even after SGID. Iskandar 
et al. (2015) observed that hydrostatic pressure at 550 
MPa for 1 min at 20°C of WPI can enhance its WPI 
ferric-reducing activity by 21% after SGID (Iskandar 
et al., 2015). Pressurized WPI subjected to SGID also 
protected intestinal cells from oxidative stress after 23 
h of treatment (Piccolomini et al., 2012).
The DH for WPI obtained in our study after SGID is 
in agreement with He et al. (2015), who showed a 49% 
digestibility by TNBS method after 3 h of digestion. 
However, these values are higher than the ones ob-
tained by Conway et al. (2013) for WPC (8.2 ± 0.5%) 
after 2 h of pepsin digestion followed by 3 h of trypsin 
treatment. The lower protein degradation was also no-
ticeable by SDS-PAGE, where, in Conway et al. (2013), 
the β-LG band was visible after the digestion process. 
Adjonu et al. (2013) also obtained DH values ranging 
between 12 and 13% for WPI hydrolyzed 12 to 24 h by 
Figure 5. Nonreducing SDS-PAGE analysis of intact and simu-
lated gastrointestinal-digested (SGID) whey proteins. Concentration 
= 6.5 μg powder/well. M = molecular weight marker; WPI = whey 
protein isolate; LF = lactoferrin; SGID control = electrolytes + pepsin 
+ pancreatin bile extract + protease inhibitor.
Table 2. Free AA released from 1 g of protein powder following simulated gastrointestinal digestion
AA, μmol/g of powder WPI1 β-LG α-LA BSA LF
Ala 2.541 2.486 1.625 2.816 3.064
Arg 2.195 2.270 1.422 4.253 4.900
Asp 0.584 0.636 0.608 0.394 0.505
Cysteic acid 0.584 0.131 0.257 0.105 0.286
Cys 1.389 1.255 1.251 1.118 1.123
γ-Aminobutyric acid   0.081   
Glu 1.823 1.347 2.596 1.766 1.498
Gly 0.884 0.639 1.482 0.788 1.563
His 1.858 1.856 1.990 2.807 2.347
Ile 2.640 2.229 2.667 1.148 1.409
Leu 7.683 8.154 6.094 7.527 6.208
Lys 7.246 6.925 8.154 6.264 5.929
Met 1.173 1.145 0.789 0.404 0.650
Methionine sulfone    0.059  
Phe 2.723 2.545 3.454 5.861 4.593
Ser 1.379 1.200 0.964 1.516 1.566
Taurine 0.217 0.278 0.582 0.243 0.187
Thr 2.633 1.585 3.269 2.380 2.608
Trp 5.067 2.462 6.955 1.722 4.235
Tyr 2.534 2.309 3.003 4.294 3.203
Val 3.632 3.218 3.183 3.069 3.111
Total 48.784 42.670 50.426 48.532 48.986
1WPI = whey protein isolate, which contains β-LG (50–60%), α-LA (15–25%), BSA (6%), lactoferrin (LF; 
<3%).
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gastrointestinal enzymes individually. This difference 
supports previous knowledge that DH can be markedly 
increased by combination of enzymes with different 
specificity (Lee and Hur, 2017), as in the INFOGEST 
protocol that more closely resembles in vivo conditions, 
and that the antioxidant activity is not defined by the 
DH (Peña-Ramos and Xiong, 2001). It is important 
to note that SGID samples in our study corresponded 
to the end of the intestinal phase. However, in vivo, 
the intestinal lumen will be exposed to these factions 
but also to less-hydrolyzed fractions arriving from the 
stomach (Dupont et al., 2010). Interestingly, Joubran 
et al. (2015) demonstrated that the antioxidant capac-
ity of α-LA increased in later digestion phases where 
an in vitro model of the infant gut was employed. The 
in vitro duodenal samples exhibited higher antioxidant 
activity than samples from an in vitro model of the 
adult duodenum. In contrast, in vitro gastric infant 
samples were less antioxidant than the adult samples. 
Antioxidant capacity of dairy proteins during gut tran-
sit is therefore not only influenced by gut location, but 
also life stage (Joubran et al.2015).
The SGID results may indicate that the release of 
free AA, in addition to individual bioactive peptides, 
governs antioxidant activity. This is supported by the 
similar antioxidant activity obtained after whey protein 
hydrolysis with different enzymes. These samples are 
abundant in AA such as histidine, phenylalanine, and 
tryptophan, which can exert their antioxidant activ-
ity by hydrogen atom transfer (i.e ORAC and ABTS) 
and by electron transfer mechanisms (i.e., FRAP; Elias 
et al. 2008). Power-Grant et al. (2016) observed that 
tryptophan has an ORAC value of 1,773,102 ± 25,218 
μmol of TE/100 g of AA dry weight, methionine has 
an ORAC value of 545,413 ± 6,528, histidine has an 
ORAC value of 191,762 ± 7,308, and cysteine has an 
ORAC value of 167,600 ± 9,077 μmol of TE/100 g of 
AA. Therefore, it was proposed that these AA play a 
major contributing role to milk protein concentrate an-
tioxidant activity. However, it is also noteworthy that 
several peptides have been identified from whey hydro-
lysates using Corolase PP [AB Enzymes, Darmstadt, 
Germany; β-LG: f(15–18) VAGT, f(19–29) WYSLA-
MAASDI, f (24–26) MAA, f(42–46) YVEEL, f(71–74) 
IIAE, f(145–149) MHIRL; Hernández-Ledesma et al., 
2005; O’Keeffe et al., 2017], thermolysin [EC 3.4.24.27; 
α-LA: f(101–104) INYW, f(115–118) LDQW; Sadat 
et al., 2011], and trypsin [β-LG: f(15–20) VAGTWY; 
Power et al., 2014]. All of these hydrolysates showed 
antioxidant activity, and the individual peptides, once 
synthetized, also demonstrated antioxidant properties. 
Therefore, the antioxidant power of whey hydrolysates 
is likely to be generated by possible synergy between 
individual AA and encrypted peptides, which are re-
leased during whey protein hydrolysis.
Whey (WPI, WPC, and fresh whey) hydrolysates 
produced by alcalase have been identified with strong 
antioxidant activity (Kou et al., 2013; Zhang et al., 
2013). We also observed that hydrolysis with alcalase 
produces hydrolysates with the highest antioxidant 
activity. Dryáková et al. (2010) observed the high-
est ABTS inhibition (54%) after hydrolysis of WPC 
with alcalase. Lin et al. (2012) also described alcalase 
hydrolysates from WPC as the most potent ferric ion-
reducing (0.55 mM FeSO4 equivalents) agents com-
pared with other commercial enzymes pepsin, trypsin, 
and flavorzyme. Alcalase and neutrase hydrolysates 
from whey proteins also protected lung fibroblast and 
umbilical vein endothelial cells by boosting intracellu-
lar antioxidant defenses (Kong et al., 2012; O’Keeffe 
and FitzGerald, 2014). In fact, the hydrolysis of β-LG 
with alcalase produced the most antioxidant fraction 
containing the peptides f(27–38) DIQKVAGTWYSL, 
f(33–38) GTWYSL, f(39–48) AMAASDISLL, f(40–48) 
MAASDISLL, f(61–73) ELKPTPEGDLEIL, f(87–98) 
IIAEKTKIPAVF, f(112–121) DTDYKKYLLF, and 
f(165–172) LSFNPTQL (Bamdad et al., 2017). It is 
important to note that antioxidant activities from com-
mercial enzyme hydrolysates in our study are likely to 
be affected by the standard thermal step required for 
enzyme inactivation, which is known to affect protein 
denaturation and aggregation (Joyce et al., 2018). In 
addition, thermal processing influenced the peptide 
release from milk proteins (Kopf-Bolanz et al., 2014).
The most potent proteins inhibiting ABTS radical 
and reducing iron were LF and α-LA; the latter was 
also the more efficient at neutralizing peroxyl radicals 
in ORAC assay. In agreement with our study, Hernán-
dez-Ledesma et al. (2005) observed that hydrolysates 
obtained from α-LA after 24 h of hydrolysis using indi-
vidual gastric enzymes had significantly higher ORAC 
values than β-LG hydrolysates (1.065 ± 0.056 and 0.701 
± 0.033 μmol of Trolox/mg of protein, respectively; 
Hernández-Ledesma et al., 2005). Camel whey protein, 
which is rich in α-LA (27%) but devoid of β-LG (Hailu 
et al., 2016), also exerted significantly higher ABTS 
radical inhibition than its bovine equivalent (Salami 
et al., 2010). However, Clausen et al. (2009) reported 
similar ORAC values for 25-μL sample quantities of in-
tact α-LA (0.07 ± 0.04 μM TE) and intact β-LG (0.14 
± 0.09 μM TE) isolated from bovine milk whey by size 
exclusion chromatography, which is in agreement with 
our ORAC values for intact α-LA and β-LG. Recently, 
bovine α-LA (97.2% protein) following an infant in vi-
tro SGID also showed higher DPPH-scavenging poten-
tial compared with intact α-LA (Joubran et al., 2017). 
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Indeed, 4 synthesized dipeptides whose sequences are 
present in α-LA sequence, EW (25–26 AA), WC (60–61 
AA), YW (103–104 AA), and WL (104–105 AA and 
118–119 AA), inhibited 50% DPPH radical at concen-
trations ranging from 0.26 to 3.07 mM (Nongonierma 
and Fitzgerald, 2013). In our study, with a DH value 
of 57%, α-LA released the highest total concentration 
(17.441 μmol of AA/g of protein) of the most reactive 
AA against peroxyl radicals (tryptophan, methionine, 
histidine, cysteine, tyrosine, and phenylalanine) as 
described by Hernández-Ledesma et al. (2005) and 
Power-Grant et al. (2016).
CONCLUSIONS
In conclusion, pre-enzymatic hydrolysis of WPI 
(based on 3 commercially available proteases tested) 
does not enhance antioxidant activity during simulated 
gut transit. This implies that the proteolytic conditions 
of the gut are capable of generating equivalent antioxi-
dant capacity during SGID of WPI. The α-LA fraction 
exerted the best antioxidant properties, which are not 
only maintained after SGID but increased. This sug-
gests that α-LA is the preferred whey protein candidate 
to supplement food products to counteract free radicals 
in our body and boost antioxidant defenses.
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